SAJJAD AHMAD

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SAINT JOSEPH, MO NPI 1013359173

General Payments — all program years on this page

$5,795.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 158
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $649.81 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $649.8121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $353.2221
2019 $2,333.1234
2020 $1,318.3513
2021 $185.4912
2022 $729.7543
2023 $225.2914
2024 $649.8121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092574195 Boston Scientific Corporation $14.86 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092574197 Boston Scientific Corporation $23.78 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101515895 E.R. Squibb & Sons, L.L.C. $15.46 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101515903 E.R. Squibb & Sons, L.L.C. $20.43 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101515907 E.R. Squibb & Sons, L.L.C. $0.91 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101515937 E.R. Squibb & Sons, L.L.C. $13.62 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101515941 E.R. Squibb & Sons, L.L.C. $181.32 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101515976 E.R. Squibb & Sons, L.L.C. $17.04 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104249333 AstraZeneca Pharmaceuticals LP $13.10 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104543736 AstraZeneca Pharmaceuticals LP $13.51 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105428337 AstraZeneca Pharmaceuticals LP $13.31 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105686901 AstraZeneca Pharmaceuticals LP $18.31 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115411706 Amgen Inc. $15.06 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115411710 Amgen Inc. $16.51 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115411715 Amgen Inc. $14.06 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125833871 Alnylam Pharmaceuticals Inc. $18.83 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131023729 PFIZER INC. $19.08 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131213664 PFIZER INC. $14.94 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131422443 PFIZER INC. $14.97 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138800548 Edwards Lifesciences Corporation $153.49 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154168894 HEARTFLOW, INC. $37.22 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.